严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）的IgG和IgA抗体反应存在性别差异；且IgG抗体在早期迅速下降。 - Suppr

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on.

作者信息

Korte Wolfgang, Buljan Marija, Rösslein Matthias, Wick Peter, Golubov Valentina, Jentsch Jana, Reut Michael, Peier Karen, Nohynek Brigitte, Fischer Aldo, Stolz Raphael, Cettuzzi Michele, Nolte Oliver

机构信息

Center for Laboratory Medicine, Frohbergstrasse 3, St. Gallen CH - 9000, Switzerland; Cantonal Corona Study Group, St. Gallen, Switzerland.

Empa - Swiss Federal Laboratories for Materials Science and Technology, St. Gallen, Switzerland; Cantonal Corona Study Group, St. Gallen, Switzerland.

出版信息

J Infect. 2021 Jan;82(1):e11-e14. doi: 10.1016/j.jinf.2020.08.032. Epub 2020 Aug 25.

DOI:10.1016/j.jinf.2020.08.032

PMID:32853597

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7445467/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7885/7445467/461a9eadc53d/gr1_lrg.jpg

相似文献

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on.

J Infect. 2021 Jan;82(1):e11-e14. doi: 10.1016/j.jinf.2020.08.032. Epub 2020 Aug 25.

Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.

J Med Virol. 2021 Feb;93(2):803-811. doi: 10.1002/jmv.26303. Epub 2020 Jul 27.

Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.

Virol J. 2021 Mar 9;18(1):52. doi: 10.1186/s12985-021-01530-2.

Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019.

PLoS One. 2020 Oct 9;15(10):e0240502. doi: 10.1371/journal.pone.0240502. eCollection 2020.

Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.

J Med Virol. 2021 Apr;93(4):2227-2233. doi: 10.1002/jmv.26646. Epub 2020 Nov 10.

Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection.

J Infect. 2021 Feb;82(2):282-327. doi: 10.1016/j.jinf.2020.09.015. Epub 2020 Sep 19.

Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays.

Diagn Microbiol Infect Dis. 2020 Nov;98(3):115140. doi: 10.1016/j.diagmicrobio.2020.115140. Epub 2020 Jul 12.

Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.

J Immunol Methods. 2021 Feb;489:112937. doi: 10.1016/j.jim.2020.112937. Epub 2020 Nov 28.

Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.

Pediatr Allergy Immunol. 2020 Oct;31(7):841-847. doi: 10.1111/pai.13278. Epub 2020 Jun 18.

Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.

Int J Mol Sci. 2021 Feb 9;22(4):1749. doi: 10.3390/ijms22041749.

引用本文的文献

Clinical Trial: Effects of Autologous Dendritic Cell Administration on Renal Hemodynamics and Inflammatory Biomarkers in Diabetic Kidney Disease.

Diseases. 2025 Apr 21;13(4):122. doi: 10.3390/diseases13040122.

Long Covid Defined.

N Engl J Med. 2024 Nov 7;391(18):1746-1753. doi: 10.1056/NEJMsb2408466. Epub 2024 Jul 31.

COVID-19 Convalescent Plasma Therapy: Long-term Implications.

Open Forum Infect Dis. 2023 Dec 29;11(1):ofad686. doi: 10.1093/ofid/ofad686. eCollection 2024 Jan.

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults.

Sci Rep. 2024 Jan 5;14(1):644. doi: 10.1038/s41598-023-51029-9.

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults.

medRxiv. 2023 Oct 2:2023.09.29.23296142. doi: 10.1101/2023.09.29.23296142.

Long-term survival after intensive care for COVID-19: a nationwide cohort study of more than 8000 patients.

Ann Intensive Care. 2023 Aug 29;13(1):76. doi: 10.1186/s13613-023-01156-3.

Kinetics of specific anti-SARS-CoV-2 IgM, IgA, and IgG responses during the first 12 months after SARS-CoV-2 infection: A prospective longitudinal study.

PLoS One. 2023 Jul 12;18(7):e0288557. doi: 10.1371/journal.pone.0288557. eCollection 2023.

No Evidence for Myocarditis or Other Organ Affection by Induction of an Immune Response against Critical SARS-CoV-2 Protein Epitopes in a Mouse Model Susceptible for Autoimmunity.

Int J Mol Sci. 2023 Jun 8;24(12):9873. doi: 10.3390/ijms24129873.

Long COVID: major findings, mechanisms and recommendations.

Nat Rev Microbiol. 2023 Mar;21(3):133-146. doi: 10.1038/s41579-022-00846-2. Epub 2023 Jan 13.

Mild COVID-19 induces early, quantifiable, persistent troponin I elevations in elder men.

Front Cardiovasc Med. 2022 Dec 1;9:1053790. doi: 10.3389/fcvm.2022.1053790. eCollection 2022.

本文引用的文献

Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2.

J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01243-20.

Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.

Aging Male. 2020 Dec;23(5):1416-1424. doi: 10.1080/13685538.2020.1774748. Epub 2020 Jun 8.

Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies.

J Clin Virol. 2020 Aug;129:104468. doi: 10.1016/j.jcv.2020.104468. Epub 2020 May 23.

The role of serology for COVID-19 control: Population, kinetics and test performance do matter.

J Infect. 2020 Aug;81(2):e91-e92. doi: 10.1016/j.jinf.2020.05.019. Epub 2020 May 15.

Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Clin Infect Dis. 2020 Nov 19;71(16):2255-2258. doi: 10.1093/cid/ciaa489.

Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan.

Intensive Care Med. 2020 Jun;46(6):1117-1120. doi: 10.1007/s00134-020-06023-4. Epub 2020 Apr 6.

Innate Immune Evasion by Human Respiratory RNA Viruses.

J Innate Immun. 2020;12(1):4-20. doi: 10.1159/000503030. Epub 2019 Oct 14.

Nasal IgA Provides Protection against Human Influenza Challenge in Volunteers with Low Serum Influenza Antibody Titre.

Front Microbiol. 2017 May 17;8:900. doi: 10.3389/fmicb.2017.00900. eCollection 2017.

Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.

J Virol. 2011 Oct;85(20):10582-97. doi: 10.1128/JVI.00671-11. Epub 2011 Jul 20.

Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.

Clin Diagn Lab Immunol. 2004 Jul;11(4):665-8. doi: 10.1128/CDLI.11.4.665-668.2004.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献